Approximately 80 percent of clinical research sites polled in a recent Complion, Inc.-sponsored survey said the costs and burden associated with administrative tasks for a single study has increased over the past two years, continuing a five-year upward trend.
Clinical researchers are looking for ways to reduce the operational challenges of clinical trials which can often occur by working with multiple sponsors. Some of these challenges include working with individual sponsor portals, using disparate processes and numerous platforms — each with a unique login credential – which can all lead to increased probability for error and placing patient safety in jeopardy.
As a result, a Shared Investigator Platform (SIP) integration, which can streamline the interaction with multiple sponsors, has become a high priority for many sites.
Complion, Inc. has joined #NoGoingBack, an industry-wide social movement which focuses on keeping in place the clinical research advancements gained during the COVID-19 pandemic.
Because research study sponsors are continually seeking efficiencies, and all stakeholders in studies have an interest in minimizing the time required of, and the potential risk to, volunteers who participate in studies, there will be a decrease in the number of single drug studies in the future. That is the observation of John Neal, CEO of PCRS Network. In the final post of this four-part series, we explore the evolution of clinical research and the opportunity for collaboration among multiple sponsors based on Neal’s insights.
Inefficient and ineffective. That’s how John Neal, CEO of PCRS Network, sums up his frank assessment of the current state of the clinical research site selection process. In the third post of this four-part series, we explore the evolution of clinical research and its impact on the site selection process based on insights presented by Neal.
We live in an age when we are surrounded by technologies that are improving the speed and efficiency with which we can gather information, and the depth and breadth of that information. In this four-part series, we explore the evolution of clinical research based on insights presented by John Neal, CEO of PCRS Network. In this second post, Neal takes a look at the area of data collection.
- Page 1 of 2